Can you show me images of subungual melanoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Subungual Melanoma: Clinical Presentation and Recognition

I cannot provide actual images, but I can describe the key clinical features of subungual melanoma (melanoma of the nails) to help you recognize this potentially deadly condition.

Key Clinical Features to Recognize

Subungual melanoma most commonly presents as longitudinal melanonychia (a brown-to-black pigmented band running from the cuticle to the nail tip), though it can also appear as nail dystrophy, ulceration, or amelanotic (non-pigmented) lesions 1, 2.

Classic Warning Signs

Look for these specific features that distinguish malignant from benign nail pigmentation:

  • Hutchinson's sign: Pigmentation extending from the nail onto the surrounding periungual skin (cuticle, nail fold, or lateral nail groove) - this is highly suspicious for melanoma 3
  • Width >3mm of the pigmented band
  • Irregular borders with blurred or variegated edges of the pigmented band
  • Color variation within the band (multiple shades of brown, black, or gray)
  • Rapid change in size, color, or morphology over weeks to months 4, 5
  • Single digit involvement in adults (benign melanonychia is often multiple digits)
  • Thumb or great toe location (most common sites) 5, 6

Atypical Presentations That Cause Diagnostic Delay

Be aware that subungual melanoma frequently masquerades as benign conditions:

  • Chronic paronychia or "infected nail" with persistent swelling and serous drainage 4, 5
  • Onychomycosis (fungal nail infection) with nail dystrophy 5, 7
  • Trauma-related changes with nail bed ulceration or granulation tissue 4
  • Amelanotic (non-pigmented) presentations appearing as red, friable masses under the nail 7
  • Wart-like or hyperkeratotic lesions 8

Critical Diagnostic Approach

When evaluating any suspicious nail lesion, maintain a low threshold for nail matrix biopsy 9, 4. The diagnostic algorithm should be:

  1. Clinical examination: Document the specific features above, photograph the lesion
  2. Dermoscopy by experienced physician enhances diagnostic accuracy 1, 2
  3. Nail matrix biopsy: Remove sufficient nail plate to adequately sample the nail matrix where melanoma arises 9, 10, 11
  4. Full-thickness excisional biopsy when possible, as partial sampling risks misdiagnosis 12

Common Diagnostic Pitfalls

The most dangerous error is attributing persistent nail changes to benign conditions without biopsy confirmation 4, 5, 7. Key mistakes include:

  • Treating presumed "chronic onychia" or "onychomycosis" for months to years without improvement
  • Accepting negative PET-CT as ruling out malignancy (early melanoma may not show on imaging) 4
  • Performing superficial shave biopsies that miss the diagnosis 9
  • Assuming trauma explains all findings without considering post-traumatic melanoma development 4

Any nail lesion that fails to respond to appropriate treatment within 6-8 weeks requires biopsy to exclude malignancy 4, 5.

Special Populations

In pediatric patients, the approach differs significantly: subungual melanoma is extraordinarily rare (only 21 cases reported), and most longitudinal melanonychia in children is benign 13. A watch-and-wait strategy with close monitoring is often appropriate in children, whereas in adults over 50 years, any new or changing longitudinal melanonychia should be biopsied 6, 13.

Acrolentiginous melanoma (the subtype affecting nails) has distinct molecular features with lower rates of BRAF mutations and potential c-Kit mutations, which becomes relevant for advanced disease treatment 1, 2.

Related Questions

Are there any laboratory tests that can reliably rule out subungual melanoma?
What are the differential diagnoses and should this pattern be evaluated for nutritional deficiencies, endocrine or systemic disease, medication‑induced pigmentation, ethnic/physiologic melanonychia, or melanocytic pathology in a patient with bilateral multiple fingernail longitudinal melanonychia (brown‑to‑black bands) and diffuse nail plate hyperpigmentation, without pitting, onycholysis, significant thickening, subungual hyperkeratosis, or overt dystrophy, that is progressively worsening each year and accompanied by scalp dandruff?
What causes a black fingernail and how is it treated?
What are the differential diagnoses and recommended work‑up for diffuse darkening of all nail beds, including how to rule out subungual melanoma?
What is the differential diagnosis and appropriate workup for a 51-year-old woman with bubble-like subungual lesions present for 6–8 months?
What is the initial workup for a patient with five days of high‑grade fever and chills without any localized source?
What are the clinical stages of atrial fibrillation?
What is the mortality risk for an underweight, frail 84-year-old female with a greater trochanter fracture?
In an adult patient with hepatocellular carcinoma and portal vein thrombosis, Child‑Pugh A liver function, ECOG performance status 0‑1, and non‑elevated AFP, what is the recommended dosing schedule for a combination of nivolumab and epirubicin?
What supplements should an adult recovering from a concussion take?
What is the recommended starting dose of quetiapine (Seroquel) for an adult with acute mania and psychotic features?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.